A drug for COVID-19 breathing problems, tested in Minnesota, shows promise

Mark Revord will never know for sure whether an experimental drug, known at the time as CM4620-IE, saved him from having a breathing tube inserted down his throat to manage his COVID-19 symptoms.

But the 59-year-old cyclist from Minneapolis took the drug as part of a small, early clinical trial after starting on low-flow oxygen in the hospital through a tube under his nose. He left Regions Hospital in St. Paul four days after starting the intravenous drug, never needing a ventilator or the breathing tube it requires.

"No one knows 100% for sure whether it worked or it didn't," Revord said in a recent interview. "My condition improved, and the [clinical trial] sure as heck didn't hurt me. In my heart, I believe it helped me."

https://www.startribune.com/a-drug-for-covid-19-breathing-problems-tested-in-minnesota-shows-promise/571026792/